Skip to main content

Table 2 Immune function parameters in peripheral blood leukocytes before (T0) and after 2 months (T2). Each value is the mean ± standard deviation of the data obtained from 31 men and women. “Placebo group” (N = 11) slept on normal beds; “Experimental group” (N = 20) used the HOGO system to avoid electromagnetic fields (EMFs). c.p.m. = counts per minute; N.S = statistically non-significant; T* = statistical tendency respect to T0

From: The use of a bed with an insulating system of electromagnetic fields improves immune function, redox and inflammatory states, and decrease the rate of aging

  Placebo Group Experimental Group
Parameters T0 T2 p-value T0 T2 p-value
Neutrophil Adherence (Adherence Index) 53 ± 17 51 ± 14 0.77 (N.S) 37 ± 16 45 ± 26 0.18 (N.S)
Lymphocyte Adherence (Adherence Index) 50 ± 17 48 ± 11 0.71 (N.S) 56 ± 19 35 ± 15 0.06 (*T)
Phagocytic efficacy (% neutrophil ingesting) 83 ± 16 83 ± 13 0.77 (N.S) 93 ± 7 91 ± 5 0.6 (N.S)
Basal lymphoproliferation (c.p.m.) 1115 ± 250 1281 ± 560 0.6 (N.S) 1176 ± 791 707 ± 291 0.09 (*T)
IL-10concentrations (pg/mL) 498.12 ± 229.7 111.31 ± 24.96 0.6 (N.S) 320.275 ± 90.4 190.69 ± 90.39 0.1 (N.S)
IL-4 concentrations (pg/mL) 104.22 ± 4.34 108.3 ± 5.2 0.99 (N.S) 39.67 ± 11.19 34.95 ± 19.78 0.98 (N.S)
IL-6 concentrations (pg/mL) 6574.9 ± 1301 5069.9 ± 1754.7 0.8 (N.S) 7100.2 ± 950.2 7130.1 ± 870.1 0.9 (N.S)
TNF-α concentrations (pg/mL) 1820.6 ± 596.8 2283.3 ± 1501.9 0.78 (N.S) 1069.9 ± 442.8 1088.5 ± 517.9 0.97 (N.S)